People can use methods such as dietary changes, supplements, diuretics, and hormone replacement to manage low parathyroid hormone levels. Hypoparathyroidism is a rare condition in which the ...
The US Food and Drug Administration (FDA) has approved palopegteriparatide (Yorvipath) for the treatment of hypoparathyroidism in adults, the drug's manufacturer Ascendis Pharma announced. In ...
ORLANDO, Fla. — After 2 years of treatment with the parathyroid hormone (PTH) analog palopegteriparatide (Yorvipath), adults with chronic hypoparathyroidism demonstrated continued improvement in renal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results